Shares of TransMedics Group Inc. (TMDX) are gaining over 11% on Wednesday morning despite no stock-related news to drive the shares.
TMDX is currently trading at $27.85, up $2.81 or 11.22%, on the Nasdaq.
TransMedics, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, will release financial results for the first quarter on Tuesday, May 4, 2021.
Analysts polled by Thomson Reuters currently estimate the company to report a loss of $0.29 per share on revenues of $7.1 million. Analysts' estimates typically exclude one-time items.
For the year-to-date period, the company's shares have traded between $17.19 and $49.50 per share.
For comments and feedback contact: editorial@rttnews.com
